Glucose Lowering Completed Phase 1 Trials for AZD-1656 (DB14810)

IndicationStatusPhase
DBCOND0046554 (Glucose Lowering)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01069926To Assess the Pharmacokinetics of AZD1656 and Its Metabolite in Type 2 Diabetes Mellitus Patients